Wells Fargo’s Adamas Pharmaceuticals ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-521
Closed -$2K 8334
2021
Q3
$2K Sell
521
-36
-6% -$175 ﹤0.01% 6632
2021
Q2
$3K Sell
557
-179
-24% -$926 ﹤0.01% 6509
2021
Q1
$3K Sell
736
-28,510
-97% -$149K ﹤0.01% 6609
2020
Q4
$127K Sell
29,246
-1,330
-4% -$5.69K ﹤0.01% 5270
2020
Q3
$126K Sell
30,576
-1,333
-4% -$5.16K ﹤0.01% 5168
2020
Q2
$81K Sell
31,909
-17,775
-36% -$52.2K ﹤0.01% 5325
2020
Q1
$144K Sell
49,684
-1,480
-3% -$6.63K ﹤0.01% 4876
2019
Q4
$194K Sell
51,164
-22,090
-30% -$106K ﹤0.01% 4965
2019
Q3
$375K Buy
73,254
+50,858
+227% +$314K ﹤0.01% 4571
2019
Q2
$138K Buy
22,396
+13,247
+145% +$76.2K ﹤0.01% 5163
2019
Q1
$65K Sell
9,149
-40,814
-82% -$367K ﹤0.01% 5260
2018
Q4
$428K Buy
49,963
+2,355
+5% +$30.6K ﹤0.01% 4427
2018
Q3
$953K Buy
47,608
+1,385
+3% +$32.5K ﹤0.01% 4005
2018
Q2
$1.19M Buy
46,223
+2,085
+5% +$57.7K ﹤0.01% 3871
2018
Q1
$1.05M Buy
44,138
+3,090
+8% +$97.4K ﹤0.01% 3874
2017
Q4
$1.39M Buy
41,048
+28,061
+216% +$784K ﹤0.01% 3672
2017
Q3
$275K Buy
12,987
+274
+2% +$5.02K ﹤0.01% 4740
2017
Q2
$222K Sell
12,713
-2,453
-16% -$40.6K ﹤0.01% 4716
2017
Q1
$266K Buy
15,166
+3,358
+28% +$57.2K ﹤0.01% 4634
2016
Q4
$200K Sell
11,808
-1,786
-13% -$27.6K ﹤0.01% 4786
2016
Q3
$223K Hold
13,594
﹤0.01% 4423
2016
Q2
$206K Sell
13,594
-354
-3% -$5.84K ﹤0.01% 4397
2016
Q1
$201K Buy
13,948
+8,352
+149% +$141K ﹤0.01% 4410
2015
Q4
$158K Sell
5,596
-15
-0.3% -$253 ﹤0.01% 4605
2015
Q3
$94K Sell
5,611
-23,263
-81% -$529K ﹤0.01% 4931
2015
Q2
$758K Buy
28,874
+26,061
+926% +$507K ﹤0.01% 3822
2015
Q1
$49K Buy
2,813
+2,677
+1,968% +$45.9K ﹤0.01% 5016
2014
Q4
$2K Buy
136
+1
+0.7% +$15 ﹤0.01% 6038
2014
Q3
$3K Sell
135
-73
-35% -$1.26K ﹤0.01% 5952
2014
Q2
$4K Buy
+208
New +$3.73K ﹤0.01% 5853